Investor Relations

H-CYTE is a medical biosciences company focused in the field of regenerative medicine. H-CYTE’s mission is to become a leader in next-generation, cellular therapeutics for the treatment of chronic health conditions.

Investor Contact Information

Company

H-CYTE, Inc
245 First St, 18th Fl
Cambridge, MA 02142

Investor Relations

LR Advisors LLC
Jason Assad
President
2020 Stone Meadow Way
Cumming, GA 30041
T: (678) 570-6791
jassad@HCYTE.com

Transfer Agent

Interwest Transfer Co., Inc.
1981 Murray Holiday Rd
Ste 100
Salt Lake City, UT 84117
T: (801) 272-9294

Investor Relations

Latest News

H-CYTE Combines Clinical Outcomes and Scientific Development to Launch New Centers for Respiratory Health

H-CYTE Announces Publication of Additional Data that Further Supports Efficacy of Innovative PRP-PBMC Treatment Aimed at Helping to Improve Overall Lung Health

H-CYTE Announces Publication of Positive Real-World Data Relating to the Use of Innovative Treatment (PRP-PBMC) Aimed at Helping Improve Overall Lung Health

Latest Financial Results

Q2 2021

Latest Annual Filing

Report Links

Sign Up For Email Alerts

Company Overview

Investor Contact Information

Company

Investor Relations

Transfer Agent